未登录

W

W. Peter Wuelfing

Merck & Co.

H指数:18

被引数:4,301

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of surfactants on the stability of therapeutic peptides under interfacial stress

表面活性剂对界面应力下治疗性肽稳定性的影响

Journal of Pharmaceutical Sciences

IF3.8

2026-09-020

PRE

Molecular Mechanisms of Liraglutide Aggregation Induced by Dual Air–Water and Silicone-Oil–Water Interfacial Stress

Molecular Pharmaceutics

IF4.5

2026-01-220

PRE

Mechanistic Investigation of Zn(II) Extraction and Interactions in Combination Biological Drug Products

Molecular Pharmaceutics

IF4.5

2026-01-200

PRE

Recurrent Neural Networks Predict Future Peptide Aggregation for Drug Development

循环神经网络预测未来肽聚集用于药物开发

MOLECULAR PHARMACEUTICS

IF4.5

2025-10-010

PRE

Rational design and relative bioperformance of high drug load grazoprevir amorphous nanoparticle formulations

理性设计和高载药量 Grazoprevir 非晶纳米粒制剂的相对生物性能

Pharmaceutical Development and Technology

IF2.5

2025-08-130

PRE

Molecular Mechanism of P53 Peptide Permeation through Lipid Membranes from Solid-State NMR Spectroscopy and Molecular Dynamics Simulations

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2024-08-071

PRE

Dose Number as a Tool to Guide Lead Optimization for Orally Bioavailable Compounds in Drug Discovery

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-01-2110

PRE

Assessing the Impact of Different Light Sources on Product Quality During Pharmaceutical Drug Product Manufacture - Fluorescent Versus Light-Emitting Diode Light

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2020-11-014

PREAI

Base-Mediated Oxidative Degradation of Secondary Amides Derived from p-Amino Phenol to Primary Amides in Drug Molecules

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2020-11-017

PREAI

Development of an automated and High throughput UHPLC/MS based workflow for cleaning verification of potent compounds in the pharmaceutical manufacturing environment

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2020-09-012

PREAI

Mechanistic understanding of abnormal reverse phase chromatographic behavior of basic analytes in the presence of sodium dodecyl sulfate

JOURNAL OF CHROMATOGRAPHY A

IF4

2019-06-010

PREAI

Enrichment of Relevant Oxidative Degradation Products in Pharmaceuticals With Targeted Chemoselective Oxidation

通过靶向化学选择性氧化富集药物中相关的氧化降解产物

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2019-04-0111

PREAI

In-Use Photostability Practice and Regulatory Evaluation for Pharmaceutical Products in an Age of Light-Emitting Diode Light Sources

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2019-03-015

PREAI

Greener Chromatographic Approaches for Dissolution Testing of Solid Pharmaceutical Formulations

用于固体药物制剂溶出度测试的绿色色谱方法

ACS SUSTAINABLE CHEMISTRY & ENGINEERING

IF7.3

2018-11-056

PREAI

Accelerated Forced Degradation of Pharmaceuticals in Levitated Microdroplet Reactors

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2018-04-3060

PREAI

Mixed Reality Meets Pharmaceutical Development

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2017-12-014

PREAI

Iron(III)-Mediated Oxidative Degradation on the Benzylic Carbon of Drug Molecules in the Absence of Initiating Peroxides

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2017-05-019

PREAI

Polysorbate 80 UV/vis spectral and chromatographic characteristics - defining boundary conditions for use of the surfactant in dissolution analysis

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2006-06-0161

PREAI

Profiling of medium chain glycerides used in pharmaceutical formulation development by reversed-phase HPLC

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2006-03-0115

PREAI

Detection and quantification of low-molecular-weight aldehydes in pharmaceutical excipients by headspace gas chromatography

JOURNAL OF CHROMATOGRAPHY A

IF4

2006-02-0173

PREAI